Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026)
Collegium Pharmaceutical (COLL) posted Asset Utilization Ratio of 0.43 for Q2 2026, down 11.34% on a QoQ basis from 0.48 in Q1 2026, and down 2.7% year-over-year from 0.44 in Q2 2025.
Analysis
Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Collegium Pharmaceutical has reported Asset Utilization Ratio for 10 years, with the latest figure at 0.43 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 2.7% year-over-year to 0.43 in Q2 2026; TTM through Jun 2026 was 0.43, a 2.7% decrease from a year earlier, with the FY2025 full-year figure at 0.47, up 4.5% from the prior year.
- Asset Utilization Ratio was 0.43 for Q2 2026 at Collegium Pharmaceutical, down from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.53 in Q2 2024, with the low at 0.25 in Q2 2022.
- Average Asset Utilization Ratio over 5 years is 0.42, with a median of 0.45 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio slumped 47.54% in 2022, then jumped 79.36% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.4 in 2022, then gained by 22.11% to 0.49 in 2023, then retreated by 21.61% to 0.38 in 2024, then climbed by 24.92% to 0.48 in 2025, then decreased by 10.77% to 0.43 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.43 (Q2 2026), 0.48 (Q1 2026), and 0.48 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 0.77 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 0.45 |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | 0.43 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.44 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.28 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.45 |